Company / Working Capital
Mirum Pharmaceuticals, Inc. Working Capital History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$343.9M
FY2025
5-year range
$124.0M / $343.9M
FY2021-FY2025
Trend
+29.2%
vs FY2024
Sector context
#126 of 213
Health Care
What the data says
At $344M, Mirum Pharmaceuticals, Inc.'s working capital ranks #126 of 213 in the Health Care sector. Working Capital has fluctuated over the past 8 years, ranging from $50M in FY2018 to $344M in FY2025.
Based on SEC 10-K filings.
$344M in FY2025 with a 5-year CAGR of +9.6%.
Improved from $300M to $344M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +39.9%
- 5-Year CAGR
- +9.6%
- 10-Year CAGR
- -
Sector benchmark
#126 of 213 in Health CareTop 59% of 213This company $343.9M Sector average $934.6M
▼
-63.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +9.6%, indicating consistent growth.
- In FY2025, working capital increased 29.2% year-over-year.
- Ranks #126 out of 213 companies in the Health Care sector.
- Lowest working capital in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -26.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $343.9M | +29.2% |
| FY2024 | $266.2M | -11.4% |
| FY2023 | $300.5M | +139.4% |
| FY2022 | $125.5M | +1.2% |
| FY2021 | $124.0M | -43.1% |
| FY2020 | $217.9M | +105.0% |
| FY2019 | $106.3M | +114.6% |
| FY2018 | $49.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026